GSK-461364

DB33590InvestigationalSmall molecule

GSK-461364: Overview.

Chemical structure of GSK-461364
Formula / weight
C27H28F3N5O2S · 543.61 g/mol (avg)
Code names
GSK-461364 · GSK-461364A

Resolves to

Compound
UNII8QO27TK6Q4CAS929095-18-1ChEMBLCHEMBL1908394ChEBI91333PubChem15983966
Structure
InChIKeyZHJGWYRLJUCMRT-QGZVFWFLSA-NSMILESC[C@@H](OC1=C(SC(=C1)N1C=NC2=CC=C(CN3CCN(C)CC3)C=C12)C(N)=O)C1=C(C=CC=C1)C(F)(F)F
Targets
P53350PLK1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with GSK-461364, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In